MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 8 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 8 samples: 2 × P53/PTEN KD,N-Myc (ChIP), vs 2 × MYCN+P53/PTEN KD,N-Myc (ChIP),Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE334560_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1475460 and SRA study SRP707239. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 4 samples.
How we read this: 2 replicated groups read from 8 sample titles; they account for 4 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9790918 P53/PTEN KD,N-Myc (ChIP), rep1 P53/PTEN KD,N-Myc (ChIP…
- GSM9790919 P53/PTEN KD,N-Myc (ChIP), rep2 P53/PTEN KD,N-Myc (ChIP…
- GSM9790920 MYCN+P53/PTEN KD,N-Myc (ChIP), rep1 MYCN+P53/PTEN KD,N-Myc …
- GSM9790921 MYCN+P53/PTEN KD,N-Myc (ChIP), rep2 MYCN+P53/PTEN KD,N-Myc …
- GSM9790922 P53/PTEN KD (Input)
- GSM9790923 MYCN+P53/PTEN KD (Input)
- GSM9790924 MYCN+P53/PTEN KD,H3K27ac (ChIP)
- GSM9790925 P53/PTEN KD,H3K27ac (ChIP)
- GSE289162 Plasticity of epigenomic aging creates vulnerabilities to early-life environmental exposures, reshaping adult cell- and direction-specific trajectories 54 samples shares vulnerabilities, creates
- GSE301496 Transient YAP/TAZ inhibition exposes therapeutic vulnerabilities in advanced cancers [CUT&Run] 20 samples shares vulnerabilities, therapeutic
- GSE301500 Transient YAP/TAZ inhibition exposes therapeutic vulnerabilities in advanced cancers [ATAC-seq] 11 samples shares vulnerabilities, therapeutic
- GSE272588 Multipotent progenitors with distinct origins, clonal lineage fates, transcriptomes, and surface markers yield two hematopoietic trees 605 samples shares progenitors, distinct
- GSE296145 SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities 36 samples shares vulnerabilities, therapeutic
- GSE310548 Distinct contributions of Etv2+ and Flk1+ progenitors to endothelial, hematopoietic, and cardiac lineages [RNA-seq] 21 samples shares progenitors, distinct
- GSE309596 Combination of PARP and KRASG12D Inhibitors Enhances Therapeutic Efficacy by Exploiting Vulnerabilities(scRNA) 12 samples shares vulnerabilities, therapeutic
- GSE255135 Pancreatic islet β-cell subtypes are derived from biochemically-distinct and nutritionally-regulated islet progenitors 10 samples shares progenitors, distinct
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.